
| 2020 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2012 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2020 | 0 | 5.979.610 | 123.999 | 1 | ||
| 2012 | 0 | 6.000.000 | 500.000 | 1 | ||
Total number of partners: 34
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 34
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2020-04-01 | Computing infrastructure for the definition, performance testing and implementation of safe-by-design approaches in nanotechnology supply chains | SbD4Nano | participant | 5.979.610 | 24 |
| 2012-09-01 | Circulating Tumor Cells TheRapeutic APheresis: a novel biotechnology enabling personalized therapy for all cancer patients | CTCTRAP | participant | 6.000.000 | 12 |